Proprietary Engineered Antibodies Completed

Clinical Study 1: Initial Results Confirm Sample Characterization Objectives

Senior Technical Advisor Mike Hale added to Scientific Advisory Board

Launched clinical sample collection study with Scripps Health; first 15 patients enrolled and specimens collected

Medical University of South Carolina added as Clinical Partner

Closed Funding Round with $2.3M Reg D Financing

First Patients Enrolled in Clinical Study

Launched First Clinical Study

Second Patent Filed

• EB-BIO Patent License Acquired
• 4000th verifi LUNG Test Cartridge Run in Lab

• Tungsten Collaborative Signed to Complete Industrial Design for ROSE Diagnostics
• Strategic Agreement Signed with AXXIN for verifi-1 Point-of-Care Reader

• Creative Destruction Lab Alumni
• $1M Seed Round Closed with Health Care Industry Angel-Lead Investors

• Provisional Patent Filed
• 1st Q-Sub Pre-Submission Meeting with FDA

Developed a 5 Minute Test Prototype

• First In-Patient Prototype Tested
• Signed Key Opinion Leaders

Developed an 8 Minute Test Prototype

Incorporation

Developed a 10 Minute Test Prototype